Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Masimo shareholders vote ‘no’ on executive pay

June 1, 2022 By Chris Newmarker

Masimo CEO Joe Kiani

Masimo CEO Joe Kiani [Image courtesy of Masimo]

Masimo (Nasdaq:MASI) shareholders recently voted to advise against the company’s compensation package for top executives.

About 53% of voting shareholders voted against the patient monitoring tech company’s handling of executive pay in what’s known as the “Say-on-Pay” vote, according to vote results of the May 26 meeting filed with the SEC yesterday. The vote comes on the heels of Say-on-Pay votes at Zimmer Biomet and Henry Schein in which support from investors was lackluster.

In fact, dozens of major U.S. companies — including JPMorgan, Intel and Coca-Cola — have faced shareholder rebukes over executive pay this year, according to a report from The Wall Street Journal. The newspaper cited the trend as part of an overall increase in investor scrutiny of corporate governance — as well as social and environmental issues.

A Masimo spokesperson could not be immediately reached for comment.

Because these are advisory votes, a corporate board doesn’t have to take action in response. Executive pay is not immediately affected — if ever. Still, Say-on-Pay votes give investors an opportunity to put the board and top executives on notice.

Masimo’s proxy statement actually showed mostly modest increases in executive compensation in 2021. Total compensation for CEO Joe Kiani, for example, was roughly $16.2 million — up nearly 4.7% from the year before. Kiani’s compensation included a roughly $1.2 million base salary and $9.0 million and $3.0 million in stock awards and option awards respectively.

A year ago, 81% of shareholder votes cast were in favor of the previous year’s compensation package for top Masimo executives, according to the proxy. With continued stockholder support, there were no significant changes to executive compensation programs in 2021.

The Masimo board’s compensation committee has believed that the current long-termed incentives equity award structure focuses the company’s named executive officers on “driving increased stockholder value over a multi-year period and enables us to achieve our retention objectives, while maintaining a conservative approach to overall share usage,” according to the proxy statement.

Masimo has been making some big moves in recent months. In April, it closed on its $1.025 billion acquisition of Viper Holdings, the parent company of Sound United and its high-end sound and home theater systems. Kiani noted in early May that there are “combined efforts to generate some exciting new product launches in consumer health and wellness.”

Masimo is also engaged in a limited consumer release of its much-anticipated W1 health watch.

Needham & Co. senior research analyst Mike Matson has a Buy rating on MASI shares. In an update posted today, Matson said: “We believe that the combination of MASI’s technologies and Sound United’s channel should drive adoption of its smartwatch and that even a niche product with limited share could become a meaningful growth driver that adds several points to MASI’s revenue growth.”

About The Author

Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.

Comments

  1. MisterBill2 says

    June 3, 2022 at 4:05 pm

    There is certainly a point at which compensation becomes obscenely excessive, It is brought about by boards of directors deciding that “it is not their money” and so they have nothing to push against excessive compensation.
    The first problem that such excess leads to is that the receiver becomes quite isolated from reality by that level of wealth.. Leaders really should be aware of how the rest of society lives.
    In addition, more should be invested back into the organization, both in development and in the rest of the employees, because without all of the workers efforts even the very best, most brilliant, leader is a soloist. (Even Mic Jagger needs a band behind him.) There are very few organizations that have no need to invest in their future.

Related Articles Read More >

Big 100: Steris logo - Largest Medical Device Companies
Steris discloses pay for top executives and its median employee
This is the logo of Tecomet.
Tecomet earns EU MDR certification
A photo of an FDA employee in the FDA Life Sciences Laboratory I in Building 64, which houses the Center for Drug Evaluation and Research and the Center for Devices and Radiological Health.
Device developers must take action as experts leave FDA
This is the logo of MedTech Innovator.
MedTech Innovator announces 65 startups for its 2025 cohort
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe